These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature. Dunphy CH; Kitchen S; Saravia O; Velasquez WS Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944 [TBL] [Abstract][Full Text] [Related]
3. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia. Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E; Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744 [TBL] [Abstract][Full Text] [Related]
4. Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood. Pillon M; Aricò M; Basso G; Locatelli F; Citterio M; Micalizzi C; Testi AM; Barisone E; Nardi M; Lombardi A; Rondelli R; Rosolen A; Pediatr Blood Cancer; 2011 Apr; 56(4):544-50. PubMed ID: 21298738 [TBL] [Abstract][Full Text] [Related]
5. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576 [TBL] [Abstract][Full Text] [Related]
6. Infusion of anti-CD10 monoclonal antibody (J5) following ablative chemotherapy in a patient with refractory pre-B acute lymphoblastic leukemia. Ruiz-Argüelles GJ; Ruiz-Argüelles A; Lobato-Mendizábal E; Presno-Bernal M; Alvarez-Amaya C Rev Invest Clin; 1991; 43(3):259-63. PubMed ID: 1840161 [TBL] [Abstract][Full Text] [Related]
7. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience. Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615 [TBL] [Abstract][Full Text] [Related]
8. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia]. Paśnicki M Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239 [No Abstract] [Full Text] [Related]
9. Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure. Layden BT; Joseph M; Tallman MS; Platanias LC Acta Haematol; 2007; 118(4):242-3. PubMed ID: 18087146 [TBL] [Abstract][Full Text] [Related]
10. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group. Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217 [No Abstract] [Full Text] [Related]
11. Parenchymal brain leukemia. Case report: problems related to the diagnosis and treatment. Corbetta A; Jankovic M; Conter V; Fuga T; Crivellaro M; Masera G Haematologica; 1991; 76(4):324-6. PubMed ID: 1794739 [TBL] [Abstract][Full Text] [Related]
12. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity. Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624 [TBL] [Abstract][Full Text] [Related]
13. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991. Mauger DC; Skeen JE N Z Med J; 1998 Nov; 111(1078):454-6. PubMed ID: 9891565 [TBL] [Abstract][Full Text] [Related]
14. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method]. Ochocka M; Zelenay E Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658 [No Abstract] [Full Text] [Related]
15. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis. Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406 [TBL] [Abstract][Full Text] [Related]
16. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia. Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428 [TBL] [Abstract][Full Text] [Related]
18. [Plasmacytoid dendritic cell tumor]. Pérez-Crespo M; Moragón M; Onrubia J; Sevila A; Alfonso R; Miralles J; Requena L Actas Dermosifiliogr; 2011 Apr; 102(3):229-31. PubMed ID: 21232729 [No Abstract] [Full Text] [Related]
19. [Late recurrence (11 years) in a case of ALL. Recurrence or a second disease?]. García Zueco JC; Torres Gómez M; López Gómez L; Martín Guerrero Y Sangre (Barc); 1992 Apr; 37(2):152-3. PubMed ID: 1621188 [No Abstract] [Full Text] [Related]
20. Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient. Papayannidis C; Iacobucci I; Abbenante MC; Curti A; Paolini S; Parisi S; Baccarani M; Martinelli G Am J Hematol; 2010 Aug; 85(8):608. PubMed ID: 20658590 [No Abstract] [Full Text] [Related] [Next] [New Search]